These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1506348)

  • 21. In vitro activity of temafloxacin against gram-negative bacteria: an overview.
    Hardy DJ
    Am J Med; 1991 Dec; 91(6A):19S-23S. PubMed ID: 1662890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibacterial activity of tosufloxacin against major organisms detected from patients with respiratory or otorhinological infections: comparison with the results obtained from organisms isolated about 10 years ago.
    Hasegawa M; Sato Y; Kanayama A; Matsuzaki K; Muraoka H; Amano A; Saika T; Kobayashi I
    J Infect Chemother; 2006 Jun; 12(3):152-6. PubMed ID: 16826349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temafloxacin: in vitro comparison with five other antibacterial agents.
    Digranes A; Hardardottir H; Bottolfsen KL
    Chemotherapy; 1991; 37(2):98-105. PubMed ID: 2032475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibility of anaerobic bacteria to tosufloxacin.
    Nord CE; Lindmark A; Persson I; Runow C
    Eur J Clin Microbiol Infect Dis; 1992 Mar; 11(3):263-5. PubMed ID: 1597207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro evaluation of E-4695, a new fluoro-naphthyridine.
    Jones RN
    Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):188-94. PubMed ID: 1327787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative in vitro activity of the new difluoro-quinolone temafloxacin (A-62254) against bacterial isolates from cancer patients.
    Rolston KV; Ho DH; LeBlanc B; Gooch G; Bodey GP
    Eur J Clin Microbiol Infect Dis; 1988 Oct; 7(5):684-6. PubMed ID: 3143585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro antibacterial activities of PD 131628, a new 1,8-naphthyridine anti-infective agent.
    Cohen MA; Huband MD; Mailloux GB; Yoder SL; Roland GE; Domagala JM; Heifetz CL
    Antimicrob Agents Chemother; 1991 Jan; 35(1):141-6. PubMed ID: 2014970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents.
    McCarter YS; Mazens-Sullivan MF; Bartlett RC
    Chemotherapy; 1992; 38(5):308-18. PubMed ID: 1337507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The in-vitro activity of CI-934 compared with that of other new 4-quinolones and nalidixic acid.
    King A; Shannon K; Slegg J; Phillips I
    J Antimicrob Chemother; 1986 Aug; 18(2):163-9. PubMed ID: 3463557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of temafloxacin hydrochloride (TA-167 or A-62254), a new fluorinated 4-quinolone.
    Nakanishi N; Inoue M; Inoue K; Yamaguchi T; Mitsuhashi S
    Chemotherapy; 1990; 36(5):345-55. PubMed ID: 2209168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibacterial activities and pharmacokinetics of E-4767 and E-5065, two new 8-chlorofluoroquinolones with a 7-azetidin ring substituent.
    Gargallo-Viola D; Ferrer S; Tudela E; Robert M; Coll R; Roser R; Guinea J
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3113-21. PubMed ID: 11600365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of trovafloxacin (CP 99,219), a new fluoroquinolone against hospital isolates.
    Ling TK; Liu EY; Cheng AF
    Chemotherapy; 1999; 45(1):22-7. PubMed ID: 9876206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro evaluation of BAY Y3118, a new full-spectrum fluoroquinolone.
    Bremm KD; Petersen U; Metzger KG; Endermann R
    Chemotherapy; 1992; 38(6):376-87. PubMed ID: 1288961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The in-vitro activity of two new quinolones: rufloxacin and MF 961.
    Wise R; Andrews JM; Matthews R; Wolstenholme M
    J Antimicrob Chemother; 1992 Jun; 29(6):649-60. PubMed ID: 1324239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of OPC-17116.
    Neu HC; Fang W; Gu JW; Chin NX
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1310-5. PubMed ID: 1329620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative in vitro activity of a new fluorinated 4-quinolone, T-3262 (A-60969).
    Espinoza AM; Chin NX; Novelli A; Neu HC
    Antimicrob Agents Chemother; 1988 May; 32(5):663-70. PubMed ID: 3293524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative study of the in vitro activity of a new fluoroquinolone, ABT-492.
    Harnett SJ; Fraise AP; Andrews JM; Jevons G; Brenwald NP; Wise R
    J Antimicrob Chemother; 2004 May; 53(5):783-92. PubMed ID: 15056651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative in vitro activity of WIN 57273, a new fluoroquinolone antimicrobial agent.
    Eliopoulos GM; Klimm K; Rice LB; Ferraro MJ; Moellering RC
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1154-9. PubMed ID: 2393275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The in-vitro activity, pharmacokinetics and tissue penetration of temafloxacin.
    Nye K; Shi YG; Andrews JM; Ashby JP; Wise R
    J Antimicrob Chemother; 1989 Sep; 24(3):415-24. PubMed ID: 2808194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of pazufloxacin, tosufloxacin and other quinolones against Legionella species.
    Higa F; Akamine M; Haranaga S; Tohyama M; Shinzato T; Tateyama M; Koide M; Saito A; Fujita J
    J Antimicrob Chemother; 2005 Dec; 56(6):1053-7. PubMed ID: 16260445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.